Interleukin-17, antagonists & inhibitors
- Name
- Interleukin-17, antagonists & inhibitors
- Accession Number
- DBCAT001936
- Description
Not Available
- Drugs
Drug Drug Description Secukinumab An immunomodulating agent and interleukin antagonist used to manage plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, along with other joint inflammatory disorders. - Drugs & Drug Targets
Drug Target Type Secukinumab Interleukin-17A target